Literature DB >> 17076659

Glutamate-stimulated ATP release from spinal cord astrocytes is potentiated by substance P.

Eryn L Werry1, Guo Jun Liu, Max R Bennett.   

Abstract

ATP has recently emerged as a key molecule mediating pathological pain. The aim of this study was to examine whether spinal cord astrocytes could be a source of ATP in response to the nociceptive neurotransmitters glutamate and substance P. Glutamate stimulated ATP release from these astrocytes and this release was greatly potentiated by substance P, even though substance P alone did not elicit ATP release. Substance P also potentiated glutamate-induced inward currents, but did not cause such currents alone. When glutamate was applied alone it acted exclusively through alpha-amino-3-hydroxy-5-methylisoxazole-4-proprionate receptors to stimulate Ca(2+) influx-dependent ATP release. However, when substance P was co-applied with glutamate, ATP release could be elicited by activation of NMDA and metabotropic glutamate receptors. Activation of neurokinin receptor subtypes, protein kinase C and phospholipases A(2), C and D were needed for substance P to bring about its effects. These results suggest that astrocytes may be a major source of ATP in the spinal cord on activation of nerve fibres that release substance P and glutamate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076659     DOI: 10.1111/j.1471-4159.2006.04133.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

2.  A quantitative model of cortical spreading depression due to purinergic and gap-junction transmission in astrocyte networks.

Authors:  Max R Bennett; Les Farnell; William G Gibson
Journal:  Biophys J       Date:  2008-10-24       Impact factor: 4.033

Review 3.  Imaging spinal cord activity in behaving animals.

Authors:  Nicholas A Nelson; Xiang Wang; Daniela Cook; Erin M Carey; Axel Nimmerjahn
Journal:  Exp Neurol       Date:  2019-06-06       Impact factor: 5.330

4.  P2X(7) Receptors in Neurological and Cardiovascular Disorders.

Authors:  Stephen D Skaper; Patrizia Debetto; Pietro Giusti
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-06-24

5.  Spinal astrocytes produce and secrete dynorphin neuropeptides.

Authors:  Andrew Wahlert; Lydiane Funkelstein; Bethany Fitzsimmons; Tony Yaksh; Vivian Hook
Journal:  Neuropeptides       Date:  2013-01-03       Impact factor: 3.286

6.  Morphine enhances microglial migration through modulation of P2X4 receptor signaling.

Authors:  Ryan J Horvath; Joyce A DeLeo
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

7.  Glutamate-mediated astrocyte-to-neuron signalling in the rat dorsal horn.

Authors:  Rita Bardoni; Alessia Ghirri; Micaela Zonta; Chiara Betelli; Giovanni Vitale; Valentina Ruggieri; Maurizio Sandrini; Giorgio Carmignoto
Journal:  J Physiol       Date:  2010-01-18       Impact factor: 5.182

Review 8.  Neuron-glia crosstalk gets serious: role in pain hypersensitivity.

Authors:  Ke Ren; Ronald Dubner
Journal:  Curr Opin Anaesthesiol       Date:  2008-10       Impact factor: 2.706

9.  Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice.

Authors:  Virginie F Labrousse; Laurence Costes; Agnès Aubert; Muriel Darnaudéry; Guillaume Ferreira; Thierry Amédée; Sophie Layé
Journal:  PLoS One       Date:  2009-06-23       Impact factor: 3.240

10.  Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation.

Authors:  Edgar Alfonso Romero-Sandoval; Ryan Horvath; Russell P Landry; Joyce A DeLeo
Journal:  Mol Pain       Date:  2009-05-28       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.